News | July 22, 2024
Vittoria Biotherapeutics Announces Peer-Reviewed Publication in Science Immunology
Read More
Press Release | July 10, 2024
Skyhawk Therapeutics Announces Positive Topline Results of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
Read More
Press Release | July 9, 2024
Interius BioTherapeutics Receives HREC Approval and CTN Clearance from the TGA to Commence a Phase 1 Clinical Trial for Its First-in-Class In Vivo CAR Therapeutic for B Cell Malignancies
Read More
Press Release | June 27, 2024
« Back Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
Read More
